Pfizer and Moderna reportedly reject invitations to Trump's vaccine 'PR stunt'
It seems the executives leading COVID-19 vaccine development know better than to attend a big gathering right about now.
On Tuesday, the White House will be hosting a "vaccine summit" apparently meant to bring vaccine developers, scientists, and government leaders together ahead of distribution of the coronavirus vaccine. But drug industry leaders have decided the event is more of a "public relations stunt," and some big names aren't even planning to attend, Stat News reports.
Pfizer and Moderna are currently at the top of the COVID-19 vaccine world, having produced vaccine candidates that are more than 90 percent effective at stopping transmission of the disease. But despite the fact that both of the companies' CEOs had been invited to the vaccine summit, neither plans to attend, two sources tell Stat. The summit comes just days before the Food and Drug Administration is set to examine Pfizer's vaccine data, and a week before it will look at Moderna's. Both reviews will likely result in emergency use authorizations for the two vaccines.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Many other companies involved in the vaccine distribution process — FedEx, UPS, Walgreens, and CVS among them — are expected to send representatives to the event. But they "are likely to send lower-ranking executives as opposed to their CEOs," sources familiar with the event's planning tell Stat. And despite an apparent conflict of interest, Peter Marks, the FDA official who heads vaccine approvals, may end up attending the summit, Stat reports.
-
Political cartoons for January 3Cartoons Saturday's political cartoons include citizen journalists, self-reflective AI, and Donald Trump's transparency
-
Into the Woods: a ‘hypnotic’ productionThe Week Recommends Jordan Fein’s revival of the much-loved Stephen Sondheim musical is ‘sharp, propulsive and often very funny’
-
‘Let 2026 be a year of reckoning’Instant Opinion Opinion, comment and editorials of the day
-
Israel approves new West Bank settlementsSpeed Read The ‘Israeli onslaught has all but vanquished a free Palestinian existence in the West Bank’
-
US offers Ukraine NATO-like security pact, with caveatsSpeed Read The Trump administration has offered Ukraine security guarantees similar to those it would receive from NATO
-
Hong Kong court convicts democracy advocate LaiSpeed Read Former Hong Kong media mogul Jimmy Lai was convicted in a landmark national security trial
-
Australia weighs new gun laws after antisemitic attackSpeed Read A father and son opened fire on Jewish families at Sydney’s Bondi Beach, killing at least 15
-
How Bulgaria’s government fell amid mass protestsThe Explainer The country’s prime minister resigned as part of the fallout
-
Benin thwarts coup attemptSpeed Read President Patrice Talon condemned an attempted coup that was foiled by the West African country’s army
-
Femicide: Italy’s newest crimeThe Explainer Landmark law to criminalise murder of a woman as an ‘act of hatred’ or ‘subjugation’ but critics say Italy is still deeply patriarchal
-
Brazil’s Bolsonaro behind bars after appeals run outSpeed Read He will serve 27 years in prison
